Huntington’s Disease is the most common neurodegenerative disorder controlled by a single gene and is characterized by motor and cognitive deficits and psychiatric symptoms. Currently, no treatments can stop or reverse the disease, but new research suggests that there might be a way to protect the brain and prevent or slow cognitive decline.
Research suggests that parts of the immune system – complement proteins and microglia – mediate the loss of specific synapses connecting the brain’s cortex and striatum. The findings, recently published in Nature Medicine, could also shed light on other neurodegenerative conditions like Alzheimer’s Disease.
In 2012, the lab was one of the first to show that microglia engulf and prune synapses during normal brain development, fine-tuning the brain’s connections. The lab also showed that complement proteins tag synapses meant for elimination. Stevens and her team speculated that in diseases involving synapse loss, like Alzheimer’s Disease, schizophrenia, and Huntington’s Disease, this pruning process is abnormally reactivated.
Huntington’s Disease offered an ideal opportunity to test their theory, both because there is a single gene associated with the condition and because it has a very well-defined pathology with specific brain regions and even select synaptic connections between neurons being impacted at early stages of the disease.
Using an animal model and postmortem brain samples from patients with Huntington’s disease, the authors showed that complement proteins and microglia are activated very early in the illness — before cognitive and motor symptoms emerge — and that they target a specific vulnerable brain circuit in the pathway connecting the cortex and striatum. Corticostriatal circuits are known to be involved in movement and learning what actions lead to positive outcomes or “reward.” The researchers saw increased levels of complement proteins, specifically around these synapses in the striatum. At the same time, inputs from neurons in other brain regions that connect to the same cells were relatively spared.
When the team blocked the complement protein C1q in their animal model — either with an antibody or by genetically deleting the complement receptor CR3 on microglia — they prevented synapse loss. They also prevented cognitive defects around visual discrimination learning and cognitive flexibility. “Some cognitive deficits tend to develop much earlier than motor defects in Huntington’s disease, and this occurs in humans, too,” notes the first author of the study. “The Huntington’s Disease model we are studying does develop some slight motor defects that are also resolved with complement blocking strategies.”
The authors showed a mechanism of specificity, selective vulnerability, and what happens at the earliest stages of Huntington’s Disease. The findings also suggest a possible biomarker: levels of innate immune molecules were elevated in the cerebrospinal fluid (CSF) of patients with Huntington’s disease, even before the appearance of motor symptoms correlating with a known predictor of pathological severity and disease onset.
“We’re excited by the idea that we could identify neuroimmune biomarkers to stratify people at the earliest stage and prioritize some for treatment,” says the senior author. “If you had clinical samples such as CSF, measuring these biomarkers could bring insight into what is happening in the brain.”
https://www.nature.com/articles/s41591-023-02566-3
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fmicroglia-and&filter=22
Microglia and complement in Huntington's disease
- 746 views
- Added
Edited
Latest News
Tumor infiltration of immun…
By newseditor
Posted 28 May
New light-controlled 'off s…
By newseditor
Posted 28 May
Gene function during embryo…
By newseditor
Posted 28 May
Formation of 3D blood vesse…
By newseditor
Posted 27 May
Liver regeneration during c…
By newseditor
Posted 27 May
Other Top Stories
How the bacterial endotoxin LPS prevents or promotes allergic disease
Read more
Genetic mechanism enables bacterial communities to organize into so…
Read more
How gut microbiota triggers inflammation from toothpaste compound t…
Read more
Epstein-Barr virus may be leading cause of multiple sclerosis
Read more
How bamboo diet keeps giant panda chubby
Read more
Protocols
SEMORE: SEgmentation and MO…
By newseditor
Posted 26 May
Spatially resolved lipidomi…
By newseditor
Posted 24 May
Efficient expansion and CRI…
By newseditor
Posted 21 May
Massively parallel in vivo…
By newseditor
Posted 20 May
Breast cancer-on-chip for p…
By newseditor
Posted 16 May
Publications
I Am Curious About Cannabis…
By newseditor
Posted 30 May
Advanced microbiome therape…
By newseditor
Posted 29 May
Hippocampal astrocytes indu…
By newseditor
Posted 29 May
TNIK's emerging role in can…
By newseditor
Posted 29 May
Diabetes drugs activate neu…
By newseditor
Posted 29 May
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar